Traws Pharma, Inc.
TRAW
$1.55
$0.021.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -778.84% | -597.51% | -557.53% | 11.94% | 0.08% |
| Total Depreciation and Amortization | -25.00% | -12.50% | 21.43% | 21.43% | 14.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10,913.99% | 9,049.50% | 9,455.39% | 7.10% | 11.01% |
| Change in Net Operating Assets | -2,083.72% | -657.18% | -281.07% | -134.11% | -120.28% |
| Cash from Operations | -66.14% | -73.60% | -37.81% | -7.69% | -10.05% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25,957.14% | -25,957.14% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -290.00% | -109.68% | -138.46% | 50.00% | 152.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.88% | -14.19% | 23.57% | -7.75% | -9.95% |